Brainomix launches e-Stroke 11 to enhance comms and workflow

By Published On: 31 January 2022

Brainomix has announced the launch of e-Stroke 11 which will enhance network communications and workflow across the platform.

The award-winning AI imaging technology analyses brain scans to flag up blockages, enabling clinicians to make better life-saving decisions.

The latest version of e-Stroke will allow physicians to quickly and securely access, review and share images and patient data, send messages, make calls via the e-Stroke app and flag patients eligible for thrombectomy.

Eric Greveson, Chief Technology Officer at Brainomix, said:

“At Brainomix, we are committed to delivering cutting-edge stroke solutions, and building on our legacy of continual innovation.

“With the launch of e-Stroke 11, we have created a tool that will allow stroke networks to strengthen the way they communicate and collaborate to support the delivery of best-in-class stroke care.”

e-Stroke is in use at around 70 NHS hospitals, with Brainomix receiving an NHSX AI grant in September 2020.

In a recent study, the implementation of Brainomix at Royal Berkshire Hospital resulted in faster treatment times and enabled more patients to achieve functional dependence.

Dr Paul Bhogal, Consultant Interventional Neuroradiologist at the Royal London Hospital, said:

“Brainomix has revolutionised the way that we are managing stroke patients.

“Its e-Stroke platform allows for fast, accurate and effective analysis of images and patient data across a stroke network – which is key for us, as we operate the largest stroke network in the UK, performing close to 300 thrombectomies a year.”

In December, the medtech company announced that it had raised £16 million in its latest funding round which will see the technology expand into new territories and indications.

The funds will allow Brainomix to develop novel biomarkers for better treatment of lung fibrosis and cancer, which have similar unmet clinical needs to stroke.

The financing was co-led by existing investors Boehringer Ingelheim Venture Fund (BIVF) and Parkwalk Advisors, alongside new investor Tencent Holdings.

Drinking within NHS guidelines can increase stroke risk
North Wales to launch multi-million-pound stroke programme